Medical News

RSS

ABC2, Exosome collaborate to explore RNA biofluid-based diagnostic technology in brain cancer

Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.

6 Feb 2012

Express Scripts subsidiary commences private offering of senior notes

Express Scripts, Inc. announced today that its wholly owned subsidiary, Aristotle Holding, Inc., a Delaware corporation, has commenced a private offering of senior notes of a benchmark amount.

6 Feb 2012

GSK voluntarily pauses enrollment in GSK2251052 clinical trials for cUTI

Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).

6 Feb 2012

Valeant divests generic Benzaclin and Efudex to Mylan

Valeant Pharmaceuticals International, Inc. today announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc..

6 Feb 2012

SDIX, BD enter collaboration for development of microbiology detection solution

SDIX, a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic and food safety applications, and BD Diagnostics, a segment of BD, a leading global medical technology company, today announced the signing of a comprehensive agreement whereby the two companies will collaborate in the development of a microbiology detection solution.

From BD (Becton, Dickinson and Company) 6 Feb 2012

Boston Scientific launches Expect 19 Flex Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation announces the global launch of the Expect 19 Flex Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples under Endoscopic Ultrasound (EUS) guidance for cancer diagnosis in organs adjacent to the gastrointestinal tract.

6 Feb 2012

HCA fourth quarter revenues increase 8.5% to $7.769 billion

HCA Holdings, Inc. today announced financial and operating results for the year and fourth quarter ended December 31, 2011. HCA also today announced that its Board of Directors approved a special cash dividend of $2.00 per share to be paid to shareholders of record as of February 16, 2012 with a payment date of February 29, 2012.

6 Feb 2012

NIH, USDA and research facilities need to protect captive great apes

The Bioethics of Great Ape Well-Being: Psychiatric Injury and Duty of Care, recently published in the Animals & Society Institute's (ASI) Public Policy series, asserts that historically and to date the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and research facilities have failed in their legal duty to protect captive great apes by not preventing foreseeable trauma of PTSD (Post Traumatic Stress Disorder) and other psychological injuries.

6 Feb 2012

Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology

Soligenix, Inc., a development stage biopharmaceutical company, announced today results from preclinical studies of its proprietary vaccine thermostabilization technology indicating that Soligenix is able to produce stable vaccine formulations using adjuvants, protein immunogens, and other components that ordinarily would not withstand long temperature variations exceeding customary refrigerated storage conditions.

6 Feb 2012

Doctor ratings increase in DrScore's 2011 Annual Report Card on Patient Satisfaction

Doctors are doing better across the board in 2011, as compared to 2010, according to DrScore's 2011 Annual Report Card on Patient Satisfaction. DrScore researchers found that overall doctor ratings have increased .5 percent and low ratings of doctors decreased by over 2 percent since 2010, based on over 36,000 ratings received in 2011.

6 Feb 2012

Sandoz sends Remodulin Paragraph IV Notice Letter to United Therapeutics

United Therapeutics Corporation today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012 from Sandoz Inc. advising that Sandoz has submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration requesting approval to market a generic version of the 10 mg/mL strength of Remodulin (treprostinil) injection.

6 Feb 2012

BioMedGPS launches new business intelligence service for life sciences industry

BioMedGPS, the leader in healthcare business intelligence and competitive metrics, announces the launch of FastTRAK B.I., a new business intelligence service designed specifically for the life science industry.

6 Feb 2012

Positive clinical results from randomized trial of InspireMD's MGuard in STEMI patients

InspireMD, Inc., a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced positive clinical results from an investigator-sponsored controlled randomized trial conducted in Chile.

6 Feb 2012

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

6 Feb 2012

First Edition: February 6, 2012

Today's headlines include reports about the continuing fall out from the Obama administration's birth control rule and the latest on the Komen foundation's efforts to bounce back from the Planned Parenthood funding flap.

6 Feb 2012

Russian neurosurgical institute acquires Leksell Gamma Knife Perfexion system

Russia's first Leksell Gamma Knife Perfexion system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow's Red Square.

From Elekta 6 Feb 2012

MindChild seeks FDA pre-market clearance for MERIDIAN non-invasive fetal heart monitor

MindChild Medical, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its MERIDIAN non-invasive fetal heart monitor.

6 Feb 2012

HEP, Verizon establish strategic relationship to encourage health IT innovation and adoption

Health Evolution Partners and Verizon Enterprise Solutions have established a strategic relationship to encourage innovation and adoption of connected health information technologies that help drive patient care improvements and better manage costs.

6 Feb 2012

EntreMed receives $9.3 million in strategic financing

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.

6 Feb 2012

Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., announced EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is now available by prescription in U.S. pharmacies for the treatment of hypertension to lower blood pressure in adults.

6 Feb 2012

Medical News

ABC2, Exosome collaborate to explore RNA biofluid-based diagnostic technology in brain cancer

Express Scripts subsidiary commences private offering of senior notes

GSK voluntarily pauses enrollment in GSK2251052 clinical trials for cUTI

Valeant divests generic Benzaclin and Efudex to Mylan

SDIX, BD enter collaboration for development of microbiology detection solution

Boston Scientific launches Expect 19 Flex Endoscopic Ultrasound Aspiration Needle

HCA fourth quarter revenues increase 8.5% to $7.769 billion

NIH, USDA and research facilities need to protect captive great apes

Soligenix reports positive results from preclinical studies of vaccine thermostabilization technology

Doctor ratings increase in DrScore's 2011 Annual Report Card on Patient Satisfaction

Sandoz sends Remodulin Paragraph IV Notice Letter to United Therapeutics

BioMedGPS launches new business intelligence service for life sciences industry

Positive clinical results from randomized trial of InspireMD's MGuard in STEMI patients

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

First Edition: February 6, 2012

Russian neurosurgical institute acquires Leksell Gamma Knife Perfexion system

MindChild seeks FDA pre-market clearance for MERIDIAN non-invasive fetal heart monitor

HEP, Verizon establish strategic relationship to encourage health IT innovation and adoption

EntreMed receives $9.3 million in strategic financing

Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News